We are live on
!
Find out more
AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+26.25%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$204M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
90.33%
Top 10 Holdings %
Top 10 Hldgs %
23.28%
Holding
107
New
107
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$6.64M |
| 2 |
Insulet
PODD
|
+$5.53M |
| 3 |
PayPal
PYPL
|
+$5.44M |
| 4 |
XYZ
Block Inc
XYZ
|
+$4.43M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.22M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.23% |
| 2 | Healthcare | 36.47% |
| 3 | Consumer Discretionary | 6% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Visa
V
$677B
| $1.95M | 0.95% |
+8,897
| New | +$1.82M |
|
52
Synopsys
SNPS
$71.5B
| $1.93M | 0.94% |
+7,428
| New | +$1.71M |
|
53
Verisk Analytics
VRSK
$26.4B
| $1.91M | 0.94% |
+9,220
| New | +$1.79M |
|
54
Illumina
ILMN
$29.4B
| $1.86M | 0.91% |
+5,161
| New | +$1.65M |
|
55
Omnicell
OMCL
$1.86B
| $1.4M | 0.69% |
+11,655
| New | +$1.14M |
|
56
Bio-Rad Laboratories Class A
BIO
$8.42B
| $1.33M | 0.65% |
+2,289
| New | +$1.3M |
|
57
Leidos
LDOS
$14.1B
| $1.2M | 0.59% |
+11,394
| New | +$1.09M |
|
58
Booz Allen Hamilton
BAH
$8.7B
| $1.19M | 0.58% |
+13,618
| New | +$1.16M |
|
59
Inspire Medical Systems
INSP
$1.42B
| $1.18M | 0.58% |
+6,292
| New | +$1.03M |
|
60
Shift4
FOUR
$3.84B
| $1.17M | 0.58% |
+15,575
| New | +$932K |
|
61
Emergent Biosolutions
EBS
$375M
| $1.09M | 0.53% |
+12,120
| New | +$1.11M |
|
62
Twist Bioscience
TWST
$5.62B
| $1.08M | 0.53% |
+7,658
| New | +$850K |
|
63
Wolfspeed
WOLF
$1.2B
| $1.01M | 0.5% |
+9,553
| New | +$767K |
|
64
Dynatrace
DT
$12.1B
| $1M | 0.49% |
+23,197
| New | +$921K |
|
65
DexCom
DXCM
$27.6B
| $997K | 0.49% |
+10,788
| New | +$963K |
|
66
BioNTech
BNTX
$22.6B
| $974K | 0.48% |
+11,950
| New | +$1.17M |
|
67
Akamai
AKAM
$16.8B
| $971K | 0.48% |
+9,246
| New | +$968K |
|
68
Alnylam Pharmaceuticals
ALNY
$36.3B
| $960K | 0.47% |
+7,390
| New | +$987K |
|
|
BEAT
69
DELISTED
BioTelemetry, Inc.
BEAT
| $941K | 0.46% |
+13,053
| New | +$683K |
|
|
SGEN
70
DELISTED
Seagen Inc. Common Stock
SGEN
| $930K | 0.46% |
+5,312
| New | +$990K |
|
71
Jack Henry & Associates
JKHY
$10.7B
| $912K | 0.45% |
+5,632
| New | +$894K |
|
|
MANT
72
DELISTED
Mantech International Corp
MANT
| $898K | 0.44% |
+10,092
| New | +$763K |
|
73
Sarepta Therapeutics
SRPT
$1.66B
| $875K | 0.43% |
+5,132
| New | +$760K |
|
|
TPIC
74
DELISTED
TPI Composites
TPIC
| $863K | 0.42% |
+16,352
| New | +$654K |
|
|
CTXS
75
DELISTED
Citrix Systems Inc
CTXS
| $857K | 0.42% |
+6,591
| New | +$838K |
|
Similar funds
JCI
SC
AOGP
ACJ
UFG
KC
P
AMC
AtonRa Partners's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for AtonRa Partners, which disclosed 107 positions worth $204M. Its ten largest holdings account for 23% of the portfolio.
Its largest position is Guardant Health: 57,704 shares worth $7.44M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, followed by Healthcare and Consumer Discretionary.
- AtonRa Partners's largest Q4 2020 buy was Guardant Health: 57,704 shares worth $7.44M.
- AtonRa Partners's ten largest holdings make up 23% of its $204M portfolio in Q4 2020.
- AtonRa Partners disclosed 107 positions in Q4 2020, its first 13F filing on record.
Based on AtonRa Partners's 13F filing for Q4 2020, filed 19 Feb 2021.